← Leaderboards
Mary F Hebert
University Of Washington
$10,258,773
Attributed
$14,183,311
Total exposure
14
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,183,311 · 14
By mechanism
U10$9,368,066 · 1
R01$4,417,919 · 2
M01$397,326 · 11
Top collaborators
- Thomas R Easterling5 shared
- Kenneth E. Thummel5 shared
- Joanne Wang4 shared
Most similar at University Of Washington
Same institution · by research overlap
- Jashvant D Unadkat$14,909,800
- Kenneth E. Thummel$18,445,737
- Thomas R Easterling$1,431,600
- Bhagwat Prasad$6,430,223
- Qingcheng Mao$5,491,198
Others in their field
Top investigators on “Pregnancy”
- Chanza Baytop · Westat, Inc.$271,217,917
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$158,777,707
- Barbara Driver · Westat, Inc.$117,058,181
- Myron S Cohen · Family Health International$101,800,876
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
Research focus
PregnancyDrug KineticsPostpartum PeriodPharmaceutical PreparationsEnzymesPregnant WomenWomanPharmacologyPhysiologicalBaseDoseFundingToxic EffectPharmacotherapyIn VitroSafetyIn VivoBasic ScienceFetusCytochrome P450GlyburideOralInfantClinical Research
Grant awards (38)
PBPK Modeling & Simulation to Predict Transporter-Mediated Drug Secretion into Human Breast Milk$744,075
R01 · FY2025 · HD · contact PI
PBPK Modeling & Simulation to Predict Transporter-Mediated Drug Secretion into Human Breast Milk$84,143
R01 · FY2025 · HD · contact PI
PBPK Modeling & Simulation to Predict Transporter-Mediated Drug Secretion into Human Breast Milk$637,191
R01 · FY2024 · HD · contact PI
PBPK Modeling & Simulation to Predict Transporter-Mediated Drug Secretion into Human Breast Milk$657,268
R01 · FY2023 · HD · contact PI
Effects of Retinoids on CYP2D6 Activity and Variability in Special Populations$549,949
R01 · FY2020 · GM · contact PI
Effects of Retinoids on CYP2D6 Activity and Variability in Special Populations$568,528
R01 · FY2019 · GM · contact PI
Effects of Retinoids on CYP2D6 Activity and Variability in Special Populations$578,648
R01 · FY2018 · GM · contact PI
Effects of Retinoids on CYP2D6 Activity and Variability in Special Populations$598,117
R01 · FY2017 · GM · contact PI
University of Washington Obstetric-fetal Pharmacology Research Unit$913,610
U10 · FY2014 · HD · contact PI
University of Washington Obstetric-fetal Pharmacology Research Unit$893,796
U10 · FY2013 · HD · contact PI
University of Washington Obstetric-fetal Pharmacology Research Unit$792,100
U10 · FY2012 · HD · contact PI
University of Washington Obstetric-fetal Pharmacology Research Unit$693,287
U10 · FY2011 · HD · contact PI
University of Washington Obstetric-fetal Pharmacology Research Unit$1,002,006
U10 · FY2010 · HD · contact PI
UW Obstetric-Fetal Pharmacology Research Unit$868,197
U10 · FY2009 · HD · contact PI
UW Obstetric-Fetal Pharmacology Research Unit$235,000
U10 · FY2009 · HD · contact PI
UW Obstetric-Fetal Pharmacology Research Unit$570,949
U10 · FY2008 · HD · contact PI
UW Obstetric-Fetal Pharmacology Research Unit$582,602
U10 · FY2007 · HD · contact PI
UW Obstetric-Fetal Pharmacology Research Unit$461,342
U10 · FY2007 · HD · contact PI
UW Obstetric-Fetal Pharmacology Research Unit$16,010
U10 · FY2007 · HD · contact PI
PK UNDER-STUDIED DRUGS IN PREGNANCY$9,439
M01 · FY2007 · RR · contact PI
ATENOLOL LACTATION STUDY$1,675
M01 · FY2007 · RR · contact PI
DRUG TRANSPORT/METABOLISM IN PREGNANCY$1,142
M01 · FY2007 · RR · contact PI
CYP3A5 AND CYCLOSPORINE/TACROLIMUS RENAL CLEARANCE$1,067
M01 · FY2007 · RR · contact PI
EFFECTS OF PREGNANCY ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF GLYBURIDE$534
M01 · FY2007 · RR · contact PI
UW Obstetric-Fetal Pharmacology Research Unit$600,000
U10 · FY2006 · HD · contact PI
DRUG TRANSPORT/METABOLISM IN PREGNANCY$100,065
M01 · FY2006 · RR · contact PI
ATENOLOL LACTATION STUDY$38,041
M01 · FY2006 · RR · contact PI
EFFECTS OF PREGNANCY ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF GLYBURIDE$16,541
M01 · FY2006 · RR · contact PI
PHARMACOKINETICS OF AMOXICILLIN DURING PREGNANCY AND POSTPARTUM$9,924
M01 · FY2006 · RR · contact PI
PK UNDER-STUDIED DRUGS IN PREGNANCY$4,962
M01 · FY2006 · RR · contact PI
UW Obstetric-Fetal Pharmacology Research Unit$902,569
U10 · FY2005 · HD
DRUG TRANSPORT/METABOLISM IN PREGNANCY$175,221
M01 · FY2005 · RR
PHARMACOKINETICS OF AMOXICILLIN DURING PREGNANCY AND POSTPARTUM$22,107
M01 · FY2005 · RR
ATENOLOL LACTATION STUDY$1,427
M01 · FY2005 · RR
UW Obstetric-Fetal Pharmacology Research Unit$836,598
U10 · FY2004 · HD
PK and PD of atenolol in pregnancy$7,374
M01 · FY2004 · RR
PK of amoxicillin during pregnancy and postpartum$7,374
M01 · FY2004 · RR
DRUG TRANSPORT/METABOLISM IN PREGNANCY$433
M01 · FY2004 · RR